Placebo intravaginal ring (IVR)

DEVICE3 trials

Sponsors

CONRAD, Marla Keller, The University of Texas Medical Branch, Galveston

Conditions

ContraceptionHIVHealthyHealthy Female Subjects

Phase 1

Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002)

TerminatedNCT02762617

Marla KellerHealthy, HIV

Start: 2017-02-24End: 2017-10-17Updated: 2018-08-21

Unknown Phase

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

CompletedNCT02602366

CONRADContraception, HIV

Start: 2016-06-06End: 2017-09-30Updated: 2018-05-18

Safety and Acceptability Study of a Placebo Antibody-Based Nonhormonal Contraceptive Intravaginal Ring

CompletedNCT06740253

The University of Texas Medical Branch, GalvestonHealthy Female Subjects

Start: 2025-02-11End: 2025-07-28Updated: 2025-09-25

Related Papers

Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial.

2019-07-1535 citations